Exemestane for Breast-Cancer Prevention in Postmenopausal Women

E. Goss, Paul; N. Ingle, James; E. Alés‐Martínez, José; M. Cheung, Angela; T. Chlebowski, Rowan; Wactawski‐Wende, Jean; McTiernan, Anne; A. Robbins, John; Johnson, Karen; W. Martin, Lisa; Winquist, Eric; E. Sarto, Gloria; E. Garber, Judy; J. Fabian, Carol; Pujol, Pascal; Maunsell, Elizabeth; Farmer, Patricia; A. Gelmon, Karen; Tu, Dongsheng; Richardson, Harriet

doi:10.1056/nejmoa1103507

Public

Exemestane for Breast-Cancer Prevention in Postmenopausal Women

Published in New England Journal of Medicine • Jun 4, 2011

Authors:

Paul E. Goss

James N. Ingle

José E. Alés‐Martínez

Abstract

BACKGROUND: Tamoxifen and raloxifene have limited patient acceptance for primary prevention of breast cancer. Aromatase inhibitors prevent more contralateral breast cancers and cause fewer side effects than tamoxifen in patients with early-stage breast cancer. METHODS: In a randomized, placebo-contr...

Subject

Medicine

Exemestane

Breast cancer

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!